O'Reilly EM - Search Results

1

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas.

Lee JK, Capanu M, O'Reilly EM, Ma J, Chou JF, Shia J, Katz SS, Gansukh B, Reidy-Lagunes D, Segal NH, Yu KH, Chung KY, Saltz LB, Abou-Alfa GK. Lee JK, et al. Br J Cancer. 2013 Aug 20;109(4):915-9. doi: 10.1038/bjc.2013.432. Epub 2013 Jul 30. Br J Cancer. 2013. PMID: 23900219 Free PMC article. Clinical Trial.

2

Irinotecan and cisplatin in upper gastrointestinal malignancies.

Enzinger PC, Ilson DH, Saltz LB, O'Reilly EM, Kelsen DP. Enzinger PC, et al. Oncology (Williston Park). 1998 Aug;12(8 Suppl 6):110-3. Oncology (Williston Park). 1998. PMID: 9726102 Review.

3

A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma.

O'Reilly EM, Ilson DH, Saltz LB, Heelan R, Martin L, Kelsen DP. O'Reilly EM, et al. Cancer Invest. 1999;17(3):195-200. doi: 10.3109/07357909909021421. Cancer Invest. 1999. PMID: 10099658 Clinical Trial.

4

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.

Ilson DH, Saltz L, Enzinger P, Huang Y, Kornblith A, Gollub M, O'Reilly E, Schwartz G, DeGroff J, Gonzalez G, Kelsen DP. Ilson DH, et al. J Clin Oncol. 1999 Oct;17(10):3270-5. doi: 10.1200/JCO.1999.17.10.3270. J Clin Oncol. 1999. PMID: 10506629 Clinical Trial.

5

5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.

Fata F, Ron IG, Kemeny N, O'Reilly E, Klimstra D, Kelsen DP. Fata F, et al. Cancer. 1999 Oct 1;86(7):1129-34. doi: 10.1002/(sici)1097-0142(19991001)86:7<1129::aid-cncr5>3.0.co;2-4. Cancer. 1999. PMID: 10506695

6

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.

Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK, Casper ES. Fata F, et al. Cancer. 1999 Nov 15;86(10):2034-7. Cancer. 1999. PMID: 10570428 Clinical Trial.

7

A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.

O'Reilly EM, Stuart KE, Sanz-Altamira PM, Schwartz GK, Steger CM, Raeburn L, Kemeny NE, Kelsen DP, Saltz LB. O'Reilly EM, et al. Cancer. 2001 Jan 1;91(1):101-5. doi: 10.1002/1097-0142(20010101)91:1<101::aid-cncr13>3.0.co;2-k. Cancer. 2001. PMID: 11148565 Clinical Trial.

8

Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.

Schwartz GK, Ilson D, Saltz L, O'Reilly E, Tong W, Maslak P, Werner J, Perkins P, Stoltz M, Kelsen D. Schwartz GK, et al. J Clin Oncol. 2001 Apr 1;19(7):1985-92. doi: 10.1200/JCO.2001.19.7.1985. J Clin Oncol. 2001. PMID: 11283131 Clinical Trial.

9

A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma.

Sanz-Altamira PM, O'Reilly E, Stuart KE, Raeburn L, Steger C, Kemeny NE, Saltz LB. Sanz-Altamira PM, et al. Ann Oncol. 2001 Apr;12(4):501-4. doi: 10.1023/a:1011135014895. Ann Oncol. 2001. PMID: 11398883 Free article. Clinical Trial.

10

Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.

Sharma S, Kemeny N, Schwartz GK, Kelsen D, O'Reilly E, Ilson D, Coyle J, De Jager RL, Ducharme MP, Kleban S, Hollywood E, Saltz LB. Sharma S, et al. Clin Cancer Res. 2001 Dec;7(12):3963-70. Clin Cancer Res. 2001. PMID: 11751488 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters